Home NDC 55111-209 Risperidone
Product NDC 55111-209
11-digit product format 551110209
Labeler code 55111
Product ID 55111-209_9293825e-f154-ffc9-20b0-5846d813b7ec
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Risperidone
Dosage form TABLET, ORALLY DISINTEGRATING
Route ORAL
Labeler Dr. Reddy's Laboratories Limited
Application ANDA077328
Marketing category ANDA
Marketing start 2009-02-24
Marketing end 0000-00-00
Substance RISPERIDONE
Active strength 2 mg/1
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 48 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 6 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A077328-001 RISPERIDONE RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 A077328-002 RISPERIDONE RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-10-05 A077328-003 RISPERIDONE RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 A077328-004 RISPERIDONE RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 A077328-005 RISPERIDONE RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 A077328-006 RISPERIDONE RISPERIDONE 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2026-09-22
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 6 · 227 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A077328-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A077328-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-10-05 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A077328-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A077328-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A077328-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A077328-006 RISPERIDONE 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2026-09-22 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A077328-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 c2088c7a36db…2026-10-15 13:18:30 2026-09 A077328-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-10-05 c2088c7a36db…2026-10-15 13:18:30 2026-09 A077328-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 c2088c7a36db…2026-10-15 13:18:30 2026-09 A077328-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 A077328-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 c2088c7a36db…2026-10-15 13:18:30 2026-09 A077328-006 RISPERIDONE 0.25MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2026-09-22 c2088c7a36db…2026-09-14 22:38:34 2026-08 A077328-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 84e616aacf4f…2026-09-14 22:38:34 2026-08 A077328-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-10-05 84e616aacf4f…2026-09-14 22:38:34 2026-08 A077328-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 84e616aacf4f…2026-09-14 22:38:34 2026-08 A077328-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 84e616aacf4f…2026-09-14 22:38:34 2026-08 A077328-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 84e616aacf4f…2026-08-18 06:07:40 2026-07 A077328-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A077328-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-10-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A077328-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A077328-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A077328-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A077328-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077328-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-10-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077328-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077328-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A077328-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077328-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077328-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-10-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077328-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077328-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077328-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A077328-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077328-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-10-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077328-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077328-004 RISPERIDONE 3MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A077328-005 RISPERIDONE 4MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-11-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077328-001 RISPERIDONE 0.5MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077328-002 RISPERIDONE 1MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-10-05 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077328-003 RISPERIDONE 2MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2009-02-24 fd3edfee7708…
Observed Orange Book normalized TE history# Normalized TE history page 6 of 6 · 227 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded risperidone ACTIVE INGREDIENT L6UH7ZF8HC RISPERIDONE TABLET, ORALLY DISINTEGRATING [DR. REDDY'S LABORATORIES LIMITED] 13 risperidone ACTIVE MOIETY L6UH7ZF8HC RISPERIDONE TABLET, ORALLY DISINTEGRATING [DR. REDDY'S LABORATORIES LIMITED] 13 aspartame INACTIVE INGREDIENT Z0H242BBR1 RISPERIDONE TABLET, ORALLY DISINTEGRATING [DR. REDDY'S LABORATORIES LIMITED] 13 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U RISPERIDONE TABLET, ORALLY DISINTEGRATING [DR. REDDY'S LABORATORIES LIMITED] 13 guar gum INACTIVE INGREDIENT E89I1637KE RISPERIDONE TABLET, ORALLY DISINTEGRATING [DR. REDDY'S LABORATORIES LIMITED] 13 magnesium stearate INACTIVE INGREDIENT 70097M6I30 RISPERIDONE TABLET, ORALLY DISINTEGRATING [DR. REDDY'S LABORATORIES LIMITED] 13 mannitol INACTIVE INGREDIENT 3OWL53L36A RISPERIDONE TABLET, ORALLY DISINTEGRATING [DR. REDDY'S LABORATORIES LIMITED] 13 peppermint INACTIVE INGREDIENT V95R5KMY2B RISPERIDONE TABLET, ORALLY DISINTEGRATING [DR. REDDY'S LABORATORIES LIMITED] 13 polacrilin potassium INACTIVE INGREDIENT 0BZ5A00FQU RISPERIDONE TABLET, ORALLY DISINTEGRATING [DR. REDDY'S LABORATORIES LIMITED] 13 silicon dioxide INACTIVE INGREDIENT ETJ7Z6XBU4 RISPERIDONE TABLET, ORALLY DISINTEGRATING [DR. REDDY'S LABORATORIES LIMITED] 13 sodium lauryl sulfate INACTIVE INGREDIENT 368GB5141J RISPERIDONE TABLET, ORALLY DISINTEGRATING [DR. REDDY'S LABORATORIES LIMITED] 13
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 55111-209-78 55111020978 10 BLISTER PACK in 1 CARTON (55111-209-78) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 10 blister pack 2009-02-24 0000-00-00 No No Current 55111-209-79 55111020979 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (55111-209-79) 2009-02-24 0000-00-00 No No Current 55111-209-81 55111020981 3 BLISTER PACK in 1 CARTON (55111-209-81) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 3 blister pack 2009-02-24 0000-00-00 No No Current